ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 24.75
+0.83 (3.47%)
Last updated: Jul 16, 2025
ChengDa Pharmaceuticals Revenue
ChengDa Pharmaceuticals had revenue of 76.31M CNY in the quarter ending March 31, 2025, a decrease of -24.37%. This brings the company's revenue in the last twelve months to 308.55M, down -25.29% year-over-year. In the year 2024, ChengDa Pharmaceuticals had annual revenue of 333.13M, down -19.59%.
Revenue (ttm)
308.55M
Revenue Growth
-25.29%
P/S Ratio
15.61
Revenue / Employee
508.32K
Employees
607
Market Cap
4.82B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |